SEC charges cardiologist with insider trading on drug trials
WASHINGTON (Reuters) - The U.S. Securities and Exchange Commission on Thursday charged a cardiologist with insider trading on confidential developments as he worked on a clinical drug trial.
No comments:
Post a Comment